Additional analyses were performed using adjusted Cox proportional hazard regression models, and no significant differences were observed for LCC, RECC, and RCC (all stages) after controlling for age, sex, CEA, histological subtype, tumor grade, pathological type, p53 expression, and MSI (Table 3). The gene discussed is TP53; the disease is neoplasm.